Novo Nordisk A/S (NONOF)

Novo Nordisk Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	450,997	461,550	304,426	256,201	162,142	136,566
Market Cap Growth	27.69%	51.61%	18.82%	58.01%	18.73%	24.84%
Enterprise Value	448,479	458,427	302,773	252,890	158,629	134,401
Last Close Price	102.84	102.10	67.99	55.30	35.71	28.81
PE Ratio	-	36.98	38.72	34.86	24.13	23.43
PS Ratio	12.89	13.40	11.97	11.90	7.77	7.45
PB Ratio	28.94	29.21	25.38	23.68	15.58	15.79
P/TBV Ratio	52.81	67.43	65.10	60.74	23.12	17.57
P/FCF Ratio	44.86	37.45	31.75	34.42	21.39	24.03
P/OCF Ratio	29.50	28.58	26.86	30.45	18.99	19.44
EV/Sales Ratio	11.79	13.31	11.91	11.74	7.60	7.33
EV/EBITDA Ratio	24.77	28.15	26.06	25.93	16.48	15.89
EV/EBIT Ratio	26.61	29.73	27.89	27.92	17.83	17.05
EV/FCF Ratio	38.57	37.20	31.57	33.97	20.93	23.64
Debt / Equity Ratio	0.47	0.25	0.31	0.38	0.16	0.08
Debt / EBITDA Ratio	0.44	0.24	0.31	0.41	0.17	0.08
Debt / FCF Ratio	0.73	0.32	0.39	0.55	0.22	0.12
Asset Turnover	0.78	0.84	0.81	0.83	0.94	1.03
Inventory Turnover	1.23	1.27	1.29	1.24	1.16	1.18
Quick Ratio	0.74	0.62	0.67	0.65	0.64	0.76
Current Ratio	0.94	0.82	0.89	0.86	0.94	1.06
Return on Equity (ROE)	88.73%	88.07%	72.00%	71.24%	69.70%	71.19%
Return on Assets (ROA)	21.47%	23.39%	21.68%	21.81%	25.01%	27.75%
Return on Capital (ROIC)	50.41%	53.53%	45.71%	43.27%	49.84%	57.33%
Earnings Yield	2.72%	2.69%	2.62%	2.85%	4.27%	4.28%
FCF Yield	2.23%	2.67%	3.15%	2.91%	4.68%	4.16%
Dividend Yield	0.49%	1.37%	1.31%	1.44%	2.09%	2.18%
Payout Ratio	46.60%	37.96%	45.57%	45.06%	47.75%	49.83%
Buyback Yield / Dilution	0.86%	1.10%	1.34%	1.58%	1.63%	1.89%
Total Shareholder Return	1.35%	2.46%	2.65%	3.02%	3.72%	4.06%

Source: S&P Capital IQ. Standard template. Financial Sources.